BHC Bausch Health Companies Inc.

23.29
+0.37  (+2%)
Previous Close 22.92
Open 23.15
Price To Book 2.58
Market Cap 8145846422
Shares 349,757,253
Volume 3,262,493
Short Ratio 1.92
Av. Daily Volume 5,060,564

SEC filingsSee all SEC filings

  1. 8-K - Current report 181236089
  2. 8-K - Current report 181203336
  3. 8-K - Current report 181167045
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 181164014
  5. 8-K - Current report 181161476

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced May 7, 2018.
Plenvu (NER1006)
Bowel cleansing
Approval announced November 2, 2017.
Latanoprostene bunod
Open angle glaucoma (OAG) or ocular hypertension (OHT)
PDUFA date February 25, 2019.
Loteprednol Gel 0.38%
Ocular Inflammation
Approval announced December 22, 2017.
LUMIFY (brimonidine tartrate ophthalmic solution 0.025%)
Eye Brightener
FDA Approval announced August 24, 2018.
IDP-121
Acne
Tentative FDA Approval announced October 8, 2018. Final approval expected November 2018 pending the expiration of exclusivity for a related product.
IDP-122
Psoriasis
Phase 3 trial to be initiated 2H 2018.
IDP-120
Acne
CRL issued June 18, 2018. New PDUFA date February 15, 2019.
DUOBRII (halobetasol propionate and tazarotene)
Psoriasis
Phase 3 trial initiated 2H 2017.
IDP-123
Psoriasis
Approved February 15, 2017.
Brodalumab
Psoriasis
Approval announced March 2, 2018.
ULTRA - 7 days
Contact lens
Phase 2 top-line data due 1H 2019.
IDP-126
Acne

Latest News

  1. Why Bausch (BHC) is Poised to Beat Earnings Estimates Again
  2. All Signals Are Positive for Buying Abbott Laboratories
  3. See what the IHS Markit Score report has to say about Bausch Health Companies Inc.
  4. Bausch Health Companies Inc. Will Release Fourth-Quarter And Full-Year 2018 Financial Results On February 20
  5. Are Insiders Buying Bausch Health Companies Inc. (NYSE:BHC) Stock?
  6. The Street Is Bullish on Facebook Stock
  7. Bausch Health (BHC) Gains But Lags Market: What You Should Know
  8. Is Bausch Health (BHC) Stock Undervalued Right Now?
  9. Bausch Health (BHC) Outpaces Stock Market Gains: What You Should Know
  10. Can Bausch Health Convince the Charts of its Comeback Story?
  11. Bausch Health's Canadian business positioned for growth in 2019
  12. Bausch is 'the most integrated eye-care company in the wo...
  13. Cramer Remix: This chipmaker could have another bad quarter—but it's worth buying now
  14. Bausch Health Guidance Brings Option Bulls
  15. Implied Volatility Surging for Bausch (BHC) Stock Options
  16. Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference
  17. The Zacks Analyst Blog Highlights: inTest, Progressive, BioTelemetry, Bausch Health and Steelcase
  18. [$$] Synergy Pharmaceuticals Wins Court Approval for Extended Sale Process
  19. Bull or Bear: Your Investment Strategy for 2019

SEC Filings

  1. 8-K - Current report 181236089
  2. 8-K - Current report 181203336
  3. 8-K - Current report 181167045
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 181164014
  5. 8-K - Current report 181161476
  6. 8-K - Current report 181150788
  7. 8-K - Current report 181150546
  8. S-8 - Securities to be offered to employees in employee benefit plans 181009240
  9. 8-K - Current report 181009060
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 18999140